Learn More
Medchemexpress LLC Avitinib maleate | 1557268-88-8 | MFCD29089376 | 99.9% | 603.60 | C30H30FN7O6 | 10 MG

Supplier: Medchemexpress LLC HY19816A10MG
Avitinib maleate is a third-generation, irreversible, orally active EGFR inhibitor supplied as the maleate salt for research use. It exhibits potent activity against EGFR L858R and T790M mutations, with reported BTK inhibitory activity, and is provided with analytical data confirming high purity. Typical formats include small solid quantities and DMSO solutions for laboratory studies.
- Third-generation, irreversible EGFR inhibitor suitable for targeted research.
- Potent activity against EGFR L858R and T790M mutants.
- Reduced potency against wild-type EGFR to aid selectivity studies.
- Maleate salt form for improved handling and stability.
- High purity with RP-HPLC documentation.
- Available in small solid pack sizes and solution formats for assays.
- Intended for in vitro and preclinical research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.